Avencell Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
500 Forge Rd, Watertown, Massachusetts, ...Phone Number
(617) 941-7468Website
www.avencell.comRevenue
$7.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Avencell Therapeutics
AvenCell Therapeutics, Inc. was recently launched by Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics and incorporated the clinical-stage biopharmaceutical company GEMoaB GmbH, now named AvenCell Europe GmbH. With $250 million in committed capital from Blackstone as its sole founding investor, AvenCell brings together switchable universal T cell technology developed by the former Cellex subsidiary GEMoaB GmbH, with a license to Intellias proprietary CRISPR/Cas9-based allogeneic platform to create a pipeline of autologous and allogeneic universal reprogrammable T cell products, focused initially on hard-to-treat cancers. AvenCells mission is to overcome the limitations of current-generation CAR-T cell therapies with an improved therapeutic window and substantially expand the types of cancer, including solid tumors, treatable with adoptive cell therapy.Explore more
Avencell Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avencell Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Avencell Therapeutics launches new products
Check if Avencell Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Avencell Therapeutics has new funding data
Earning: See what the market has to say on Avencell Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Avencell Therapeutics
Avencell Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Avencell Therapeutics is spiking on competitors!
Click to see if Avencell Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Avencell Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Avencell Therapeutics
Compare insights from companies similar to Avencell Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avencell Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avencell Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avencell Therapeutics.
Avencell Therapeutics financials insights
Gather financial insights about Avencell Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$112M
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Product Management, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Left Company
Executive Move
Executive Moves, Left Company
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avencell Therapeutics
Sign Up For FreeTo access detailed company insights
AvenCell Therapeutics, Inc. was recently launched by Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics and incorporated the clinical-stage biopharmaceutical company GEMoaB GmbH, now named AvenCell Europe GmbH. With $250 million in committed capital from Blackstone as its sole founding investor, AvenCell brings together... Read More
